Alembic Ltd. News and Updates

Keep track of all breaking news on Alembic Ltd. from all sources in a single place.

Load latest

Alembic Ltd.

25 Mar 2022, 11:04AM

103.00

-1.14%

Alembic Pharma targets 10-12 product filings from Karkhadi facility

Business Standard

Resolution of the observations made by the USFDA (for which Alembic has already responded to the regulator) is critical for Alembic's US business

Alembic Ltd. has lost -27.16% in the last 1 Year

Alembic Ltd.

01 Feb 2022

103.00

-1.14%

Alembic gets USFDA approval to market Clarithromycin tablets in America

Moneycontrol

The company has received the final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Clarithromycin tablets in strengths of 250 mg and 500 mg, the drug firm said in a regulatory filing.

Alembic Ltd. has lost -27.16% in the last 1 Year

Alembic Ltd.

10 Jan 2022

103.00

-1.14%

Alembic gets USFDA nod to market generic product

Moneycontrol

The company has received tentative approval from the US Food Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for its medication in strength of 400 mg, the drug maker said in a statement.

Alembic Ltd. is trading below all available SMAs

Alembic Ltd.

04 Jan 2022

103.00

-1.14%

Alembic gets USFDA nod for generic drug to treat bacterial infections

Business Standard

The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Doxycycline Hyclate delayed-release tablets

Alembic Ltd. is trading below all available SMAs

Alembic Ltd.

08 Dec 2021

103.00

-1.14%

Alembic gets USFDA nod for generic hypertension treatment drug

Business Standard

Alembic said it has so far received 15 product approvals this year

Alembic Ltd. is trading below all available SMAs

Alembic Ltd.

01 Dec 2021

103.00

-1.14%

Glenmark, Alembic, Cipla: Pharma stocks on a booster dose this December

Business Standard

Select pharma stocks look good on the technical charts and may jump up to 15 per cent in December. On the fundamental side, fears of Omicron variant spreading may also keep them in news and buzzing

Alembic Ltd. has lost -27.16% in the last 1 Year

Alembic Ltd.

23 Nov 2021

103.00

-1.14%

US FDA nod for Alembic's ANDA

Business Line

Formoterol Fumarate Inhalation Solution is used to treat chronic obstructive pulmonary disease

Alembic Ltd. is trading below all available SMAs

Alembic Ltd.

11 May 2021

103.00

-1.14%

Alembic Consolidated March 2021 Net Sales at Rs 28.89 crore, up 151.66% Y-o-Y

Moneycontrol

NULL

Alembic Ltd. is trading below all available SMAs

Alembic Ltd.

09 Feb 2021

103.00

-1.14%

Alembic's affiliate Rhizen bags US FDA nod for oral lymphoma drug

Business Standard

Company says a critical cancer inhibiting component in the formulation is the first new chemical entity discovered by Indian scientists to secure US FDA nod